FindTrial
Sign In

Analgesic effect of esketamine combined with ultrasound-guided transverse abdominal plane block in pediatric laparoscopic unilateral inguinal hernia repair

Analgesic effect of esketamine combined with ultrasound-guided transverse abdominal plane block in pediatric laparoscopic unilateral inguinal hernia repair

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071345
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-15
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic effect in pediatric laparoscopic unilateral inguinal hernia repair

Interventions

Blank group:0.4ml/kg 0.25% ropivacaine
Dexmedetopyrimidine group:0.4ml/kg 0.25% ropivacaine + 1µg/kg dexmedetomidine
esketamine group:0.4ml/kg0.25% ropivacaine + 0.5mg/kg esketamine

Sponsors

Quanzhou First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: Children undergoing laparoscopic unilateral inguinal hernia repair

Exclusion criteria

Exclusion criteria: (1) Recent upper respiratory tract infection; (2) Children with other organic lesions; (3) Children with congenital heart disease and severe developmental delay; (4) Have a history of drug allergy; (5) The parents of the child do not agree.

Design outcomes

Primary

MeasureTime frame
PEAD Score;FLACC Score;Total amount of analgesics;—

Secondary

MeasureTime frame
age;gender;body mass index;ASA grade;Athens sleep self-measurement table;Guardian satisfaction;—

Countries

China

Contacts

Public ContactWenqin Xie

Quanzhou First Hospital

714893291@qq.com+86 135 9926 9966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026